HFCAS OpenIR

浏览/检索结果: 共2条,第1-2条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2021
作者:  Xu, Xiaoling;  Wang, Ding;  Chen, Wei;  Li, Na;  Suwinski, Rafal;  Rossi, Antonio;  Rosell, Rafael;  Zhong, Jianxiang;  Fan, Yun
收藏  |  浏览/下载:76/0  |  提交时间:2022/02/14
Immune checkpoint inhibitor (ICI)  non-small cell lung cancer (NSCLC)  peripheral blood lymphocyte subsets  
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing;  Xu, Chunwei;  Lou, Guangyuan;  Shao, Lan;  Xu, Yibing;  Wang, Qian;  Wang, Siyuan;  Gao, Wenbin;  Zhang, Yiping;  Song, Zhengbo
收藏  |  浏览/下载:67/0  |  提交时间:2022/01/10
Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event